Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Carcinogenesis

Abstract #2349: Mtgr1 is a tumor modifier in inflammatory carcinogenesis in the colon

Caitlyn Whitten, Amanda Williams, Scott Hiebert and Christopher Williams
Caitlyn Whitten
Vanderbilt University, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Williams
Vanderbilt University, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Hiebert
Vanderbilt University, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher Williams
Vanderbilt University, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2009
  • Article
  • Info & Metrics
Loading
AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO

Abstract

MTGR1 (Myeloid Translocation Gene, Related-1) is a member of a gene family originally identified as targets of chromosomal translocation in acute myeloid leukemia (AML). Recent work from our laboratory has shown that MTGR1 plays a role in intestinal differentiation, wound healing, and inflammation and that this, in part, occurs via MTG-mediated repression of TCF4. Given the role of MTG family members in hematopoietic malignancy, the ability of MTGR1 to modulate WNT signaling, and the fact that loss of MTGR1 results in sensitization to gut injury, we hypothesized that MTGR1 may influence tumorigenesis arising in an inflammatory background. The AOM/DSS model is a robust model for interrogating modifiers of intestinal carcinogenesis. 19 C57bl6 Mtgr1-/- and 22 WT mice were injected with 12 mg/kg AOM followed 5 days later with the first of four cycles of 4 days of 3% DSS ad lib, with each cycle separated by 16 days of recovery and animals sacrificed 1 month after the last cycle of DSS treatment. Two hours prior to sacrifice 16.5 ug/kg of BrdU was injected IP. At necropsy colons were isolated and tumor burden, size and distribution scored. IHC for BrdU, \#946;-catenin, COX-2, and CD3 was performed. RNA was isolated and expression array analysis performed using the Affymetrix Mouse Gene 1.0 platform. Mtgr1-/- mice were protected from tumorigenesis with decreased tumor number (1.7 vs 7.5 polyps per colon, p<0.001), decreased multiplicity, and reduced surface area per lesion (27 vs 82 mm2, p=0.01). Mtgr1-/- tumors had similar proliferation, but significantly higher intra-tumoral apoptosis rates when compared to WT tumors, potentially explaining the difference in size and number (32 vs 13 TUNEL (+) cells/HPF, p<0.001). Panther analysis of mRNA expression array data from Mtgr1-/- vs WT tumor samples revealed significant upregulation of inflammatory networks and a decrease in WNT signaling networks in the Mtgr1-/- tumors (p<0.001). In support of these observations, \#946;-catenin IHC showed decreased nuclear \#946;-catenin and CD3+ IHC revealed increased T-cell infiltrate in Mtgr1-/- tumors (49.4 vs 13.6 CD3+ cells/hpf, p<0.001). MTGR1-specific TaqMan analysis of Origene TissueScan Cancer surveys revealed a trend towards increased expression in breast, colon, prostate and lung carcinoma. Surveying of matched colorectal cancer and normal tissue revealed heterogeneity in expression with 68% of samples showing increased Mtgr1 expression. These studies provide the first evidence that MTGR1 may function as a tumor promoter in intestinal carcinogenesis.

Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 2349.

Footnotes

  • 100th AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO

  • American Association for Cancer Research
Back to top
Cancer Research: 69 (9 Supplement)
May 2009
Volume 69, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract #2349: Mtgr1 is a tumor modifier in inflammatory carcinogenesis in the colon
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract #2349: Mtgr1 is a tumor modifier in inflammatory carcinogenesis in the colon
Caitlyn Whitten, Amanda Williams, Scott Hiebert and Christopher Williams
Cancer Res May 1 2009 (69) (9 Supplement) 2349;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract #2349: Mtgr1 is a tumor modifier in inflammatory carcinogenesis in the colon
Caitlyn Whitten, Amanda Williams, Scott Hiebert and Christopher Williams
Cancer Res May 1 2009 (69) (9 Supplement) 2349;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Carcinogenesis

  • Abstract LB-094: Regorafenib and sildenafil interact to kill tumor cells
  • Abstract LB-093: Activation of the FGFR1 signaling pathway by the epstein-barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells
  • Abstract LB-087: A facilitative role for caspase 3 in promoting genetic instability and carcinogenesis
Show more 3

Models and Mechanisms of Carcinogenesis -- Poster Presentations - Proffered Abstracts

  • Abstract #2355: Bipotential progenitor cells give rise to hepatocellular carcinoma in liver specific Pten-null mice
  • Abstract #2369: Effects of epigallocatechin gallate (EGCG) on UV radiation-induced lipid peroxidation products in skin cancer models.
  • Abstract #2348: RasHa activation interdicts compensatory p53/p21WAF expression in Fos/PTENnull skin carcinogenesis via initial p53 loss, but retention of p21WAF limits malignant progression.
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement